The limitation of a single sector approach. HNP Discussion Paper
For practitioners in humanitarian and development contexts
Celebrating ten years of success 2004-2014
Capability and Performance
KNCV Tuberculosis Foundation - Your Partner in the fight against TB
Accessed November 2017
13280–13285 / PNAS / September 9, 2008 / vol. 105 / no. 36
Eur Respir J 2016; 48: 808–817 | DOI: 10.1183/13993003.00840-2016
Special summit of African Union on HIV and Aids, Tuberculosis and Malaria (atm) Abuja, Nigeria 2–4 may, 2006Sp/Assembly/ATM/2 (I), Rev.3
Abuja call for accelerated action towards universal access to HIV and Aids, Tuberculosis and Malaria services in Africa
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf...ections. Clofazimine resistance is still rare but this antimicrobial cannot be given alone
more